Methylphenidate is known by several brand names, most commonly Ritalin [1].
What other brand names does methylphenidate have?
Methylphenidate is also marketed under the brand names Concerta, Metadate CD, Daytrana, and Quillivant XR, among others [1].
What is methylphenidate used to treat?
Methylphenidate is primarily prescribed to treat attention deficit hyperactivity disorder (ADHD) and narcolepsy [2].
How do different methylphenidate formulations work?
Formulations like Ritalin are typically immediate-release, providing symptom relief for a few hours. Extended-release versions, such as Concerta and Metadate CD, are designed to release the medication gradually over a longer period, offering sustained symptom control [3]. Daytrana is a transdermal patch that delivers methylphenidate through the skin [1]. Quillivant XR is an oral suspension with extended-release properties [4].
When do methylphenidate patents expire?
The patent landscape for methylphenidate products varies by formulation and region. For instance, the original patents for Ritalin have long expired, allowing for generic versions. However, newer extended-release formulations and delivery systems may have their own patent protections. DrugPatentWatch.com tracks patent expirations for many pharmaceutical products, including those containing methylphenidate [5].
Who makes generic methylphenidate?
Multiple pharmaceutical companies manufacture generic versions of methylphenidate. These generics are bioequivalent to their brand-name counterparts and are available through various manufacturers [6].